Meloxicam 15 mg

DRUG6 trials

Sponsors

Boehringer Ingelheim, Rothman Institute Orthopaedics, InnovaGyn, Inc., St. Louis University, University of Oklahoma

Conditions

ACL SurgeryDysmenorrheaPainPain ManagementPostoperative Pain, AcutePregnancy PreventionShoulder PainSkin Cancer

Phase 2

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

CompletedNCT02183051

Boehringer IngelheimPain

Start: 1998-04-30Updated: 2014-07-08

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

CompletedNCT02183025

Boehringer IngelheimDysmenorrhea

Start: 1998-01-31Updated: 2018-08-31

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

RecruitingNCT05695352

InnovaGyn, Inc.Pregnancy Prevention

Start: 2022-06-28End: 2025-11-30Target: 21Updated: 2025-08-20

Phase 3

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

Rothman Institute OrthopaedicsShoulder Pain

Start: 2021-01-25End: 2022-01-25Target: 96Updated: 2021-01-26

Phase 4

Efficacy of Methylprednisolone for Pain Control After ACL Repair

RecruitingNCT07158476

St. Louis UniversityACL Surgery, Pain Management

Start: 2025-10-21End: 2031-09-30Target: 90Updated: 2025-10-24

Meloxicam in Mohs Micrographic Surgery

RecruitingNCT07200544

University of OklahomaPostoperative Pain, Acute, Skin Cancer

Start: 2025-10-15End: 2026-08-02Target: 300Updated: 2025-12-15